coronavirus
Fauci Denigrates Trump Admin’s ‘Rather Vague’ Vaccine Rollout Plan
By
02.16.21 | 1:39 pm
WASHINGTON, DC - AUGUST 23: FDA Commissioner Stephen Hahn looks on as President Donald Trump announces that the Food and Drug Administration is issuing an emergency authorization for blood plasma as a coronavirus treatment during a press conference in James S. Brady Briefing Room at the White House on on August 23, 2020 in Washington, DC. The move by the FDA comes after President Trump accused the FDA of slow-walking the therapy to harm his reelection chances.(Photo by Pete Marovich/Getty Images) WASHINGTON, DC - AUGUST 23: FDA Commissioner Stephen Hahn looks on as President Donald Trump announces that the Food and Drug Administration is issuing an emergency authorization for blood plasma as a coronavirus treatment during a press conference in James S. Brady Briefing Room at the White House on on August 23, 2020 in Washington, DC. The move by the FDA comes after President Trump accused the FDA of slow-walking the therapy to harm his reelection chances.(Photo by Pete Marovich/Getty Images)
Trump’s FDA Chief: More ‘Safeguards’ Needed Against Presidential Pressure
By
02.08.21 | 11:54 am
Biden Admin Uses Wartime Powers To Boost Fed Role In Vaccine Distribution
By
02.05.21 | 12:03 pm
in Super Bowl LII at U.S. Bank Stadium on February 4, 2018 in Minneapolis, Minnesota. in Super Bowl LII at U.S. Bank Stadium on February 4, 2018 in Minneapolis, Minnesota.
Biden Hopes To Convert Anti-Maskers In Super Bowl Video Message
By
02.05.21 | 10:40 am
Biden Admin Is Considering Mailing Masks To American Households
By
02.04.21 | 9:00 am
In this photo Dec. 25, 2020 released by Xinhua News Agency, packages of COVID-19 inactivated vaccine products are seen at a production plant of the Beijing Biological Products Institute Co., Ltd, a unit of state-owned Sinopharm in Beijing. The Chinese drugmaker said Wednesday, Dec. 30, 2020 its coronavirus vaccine was found to be 79.3% effective at preventing infection in preliminary data from the final round of testing, moving Beijing closer to possibly being able to fulfill its pledge to supply other developing countries.(Zhang Yuwei/Xinhua via AP) In this photo Dec. 25, 2020 released by Xinhua News Agency, packages of COVID-19 inactivated vaccine products are seen at a production plant of the Beijing Biological Products Institute Co., Ltd, a unit of state-owned Sinopharm in Beijing. The Chinese drugmaker said Wednesday, Dec. 30, 2020 its coronavirus vaccine was found to be 79.3% effective at preventing infection in preliminary data from the final round of testing, moving Beijing closer to possibly being able to fulfill its pledge to supply other developing countries.(Zhang Yuwei/Xinhua via AP)
What A ‘Forever War’ Against COVID Would Mean Prime Badge
By
02.03.21 | 6:07 pm
Noem Pats Herself On The Back For ‘Unique’ COVID Approach. SD Has Been Hit Especially Hard.
By
02.03.21 | 10:50 am
What The COVID Relief Counterproposal From Senate GOPers Leaves Out
By
02.01.21 | 6:09 pm
Biden Administration Eyes Push To Clear Up Key Vaccine Bottleneck
By
01.29.21 | 5:25 pm
Some Red States Welcome Increased Federal Role In Biden Vaccine Rollout
By
01.28.21 | 2:06 pm